会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明申请
    • NON-HYDROGENATED FAT COMPOSITION
    • WO2021107857A1
    • 2021-06-03
    • PCT/SE2020/051141
    • 2020-11-27
    • AAK AB
    • DEMEURISSE, JeroenMERCKAERT, Laure-Anne
    • C11C3/10A23G1/00A23G1/38
    • A non-hydrogenated fat composition comprises a non-hydrogenated fat composition comprising at least 10% by weight stearic acid (C18:0) fatty acid residues, at least 0.2% by weight butyric acid (C4:0) fatty acid residues, and at least 0.2% by weight caproic acid (C6:0) fatty acid residues, based on the total C4-C24 fatty acid residues; the non-hydrogenated fat composition being obtainable by subjecting a precursor composition to an interesterification process to produce an interesterified composition and optionally blending the interesterified composition with a further triglyceride composition; wherein the precursor composition comprises: a triglyceride comprising at least 10% stearic acid (C18:0) fatty acid residues; and a non-hydrogenated milk fat; and further wherein the weight ratio of the triglyceride comprising stearic acid (C18:0) fatty acid residues to the non-hydrogenated milk fat is in the range 40:60 to 95:5. Also provided are a process for producing the composition, a dough comprising the non-hydrogenated fat composition and various food products comprising the non-hydrogenated fat composition.
    • 20. 发明申请
    • METHOD FOR PROVIDING A CONTROL FOR USE IN A SCREEN FOR PATHOGENIC VIRUS
    • 提供用于病原体病毒的屏幕中的控制的方法
    • WO2017060662A1
    • 2017-04-13
    • PCT/GB2015/052935
    • 2015-10-07
    • THE SECRETARY OF STATE FOR HEALTH
    • MATTIUZZO, GiadaPAGE, Mark
    • C12N15/867C12Q1/70C12N7/02
    • C12Q1/702C12N2740/16043C12N2760/14122C12Q2600/166
    • The present invention provides a method for providing a control for use in a screen for a pathogenic virus comprising: a. performing ribonucleic acid (RNA) extraction on a recombinant RNA virus, wherein: i. said recombinant RNA virus comprises a control RNA sequence for identification of the presence or absence of a pathogenic RNA virus; ii. the control RNA sequence comprises at least 3 kb contiguous nucleotide sequence of said pathogenic RNA virus or a complement thereof; and iii. the recombinant RNA virus is a Lentivirus or a Gammaretrovirus; and b. providing an isolated recombinant RNA virus sequence. The invention also provides uses, nucleotide sequences, vectors, ribonucleic acids, deoxyribonucleic acids, compositions, kits, methods for manufacture and for detecting the presence or absence of a pathogenic virus.
    • 本发明提供了一种用于提供用于病原体病毒筛选的控制的方法,包括:a。 在重组RNA病毒上进行核糖核酸(RNA)提取,其中:i。 所述重组RNA病毒包含用于鉴定病原RNA病毒存在或不存在的对照RNA序列; II。 对照RNA序列包含所述病原RNA病毒的至少3kb连续核苷酸序列或其补体; 和iii。 重组RNA病毒是慢病毒或加马马拉病毒; 和b。 提供分离的重组RNA病毒序列。 本发明还提供了用途,核苷酸序列,载体,核糖核酸,脱氧核糖核酸,组合物,试剂盒,用于制造和检测病原体病毒存在或不存在的方法。